State Street Corporation 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-10 07:39 am Sale | 2022-12-31 | 13G | Heron Therapeutics, Inc. HRTX | STATE STREET CORP STT | 2,586,932 2.180% | -10,336,437 (-79.98%) | Filing |
| 2022-04-11 2:02 pm Purchase | 2022-03-31 | 13G | Heron Therapeutics, Inc. HRTX | STATE STREET CORP STT | 12,923,369 12.650% | 5,230,958 (+68.00%) | Filing |
| 2022-02-11 09:52 am Purchase | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | STATE STREET CORP STT | 7,692,411 7.550% | 7,692,411 (New Position) | Filing |